About this trial
COESIT aims to establish a network of reference laboratories in the central-southern regions of Italy for the genetic and molecular characterization of tumors, with the goal of implementing precision and personalized oncology in clinical practice.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Cancer patients
Patients from the central-southern regions
Disqualifiers
None
Trial population
Cancer patients from the central-southern regions of Italy diagnosed with lung, breast, colorectal, ovarian, liver, bile duct, pancreatic, and gastric cancers.
Trial design
Other
Other
Treatments tested in this trial
Creation of a laboratory network
Other interventionCreation of a laboratory network in Central-Southern Italy capable of performing complex genomic analyses.
Mapping of genomic alterations
Other interventionMapping of genomic alterations aimed at precision medicine and personalized diagnostic and therapeutic approaches.
Creation of a bioinformatics network among the participating institutions.
Other interventionCreation of a bioinformatics network among the participating institutions.
Development of a platform for the collection of clinicopathological and genetic-molecular data.
Other interventionDevelopment of a platform for the collection of clinicopathological and genetic-molecular data.
Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.
Other interventionIdentification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.
Treatment groups
Trial outcomes
Primary outcomes
Improvement of diagnostic precision in oncology based on advanced molecular profiling tools.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.